HealthEquity [HQY] vs Veeva Systems [VEEV] Detailed Stock Comparison
HealthEquity
NASDAQ
Loading...
Veeva Systems
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: HealthEquity wins in 5 metrics, Veeva Systems wins in 14 metrics, with 0 ties. Veeva Systems appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | HealthEquity | Veeva Systems | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 65.16 | 59.15 | Veeva Systems |
| Price-to-Book Ratio | 3.64 | 7.33 | HealthEquity |
| Debt-to-Equity Ratio | 52.11 | 1.24 | Veeva Systems |
| PEG Ratio | 24.19 | 1.48 | Veeva Systems |
| EV/EBITDA | 21.05 | 48.88 | HealthEquity |
| Profit Margin (TTM) | 9.80% | 27.34% | Veeva Systems |
| Operating Margin (TTM) | 25.50% | 30.79% | Veeva Systems |
| EBITDA Margin (TTM) | 25.50% | 30.79% | Veeva Systems |
| Return on Equity | 5.77% | 14.06% | Veeva Systems |
| Return on Assets (TTM) | 4.57% | 6.90% | Veeva Systems |
| Free Cash Flow (TTM) | $-165.60M | $1.09B | Veeva Systems |
| 1-Year Return | 20.05% | 45.77% | Veeva Systems |
| Price-to-Sales Ratio (TTM) | 6.21 | 15.98 | HealthEquity |
| Enterprise Value | $8.54B | $39.63B | Veeva Systems |
| EV/Revenue Ratio | 6.87 | 13.88 | HealthEquity |
| Gross Profit Margin (TTM) | 67.80% | 77.10% | Veeva Systems |
| Revenue per Share (TTM) | $14 | $18 | Veeva Systems |
| Earnings per Share (Diluted) | $1.37 | $4.72 | Veeva Systems |
| Beta (Stock Volatility) | 0.54 | 0.96 | HealthEquity |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
HealthEquity vs Veeva Systems Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| HealthEquity | 2.81% | -3.40% | -6.54% | -7.95% | -20.62% | -7.15% |
| Veeva Systems | 2.05% | -0.54% | 0.46% | 16.15% | 20.52% | 33.26% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| HealthEquity | 20.05% | 46.16% | 66.28% | 207.11% | 430.32% | 430.32% |
| Veeva Systems | 45.77% | 28.01% | 5.12% | 1,057.15% | 532.15% | 532.15% |
Performance & Financial Health Analysis: HealthEquity vs Veeva Systems
| Metric | HQY | VEEV |
|---|---|---|
| Market Information | ||
| Market Cap | $7.72B | $45.62B |
| Market Cap Category | Mid cap | Large cap |
| 10 Day Avg. Volume | 981,810 | 1,023,150 |
| 90 Day Avg. Volume | 898,080 | 1,195,860 |
| Last Close | $89.89 | $280.61 |
| 52 Week Range | $71.33 - $116.65 | $190.38 - $296.72 |
| % from 52W High | -22.94% | -5.43% |
| All-Time High | $116.65 (Jun 05, 2025) | $343.96 (Aug 02, 2021) |
| % from All-Time High | -22.94% | -18.42% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.15% | 0.17% |
| Quarterly Earnings Growth | 0.87% | 0.41% |
| Financial Health | ||
| Profit Margin (TTM) | 0.10% | 0.27% |
| Operating Margin (TTM) | 0.26% | 0.31% |
| Return on Equity (TTM) | 0.06% | 0.14% |
| Debt to Equity (MRQ) | 52.11 | 1.24 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $24.49 | $38.11 |
| Cash per Share (MRQ) | $3.33 | $37.14 |
| Operating Cash Flow (TTM) | $339.16M | $1.20B |
| Levered Free Cash Flow (TTM) | $96.00M | $1.05B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: HealthEquity vs Veeva Systems
| Metric | HQY | VEEV |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 65.16 | 59.15 |
| Forward P/E | 24.19 | 41.30 |
| PEG Ratio | 24.19 | 1.48 |
| Price to Sales (TTM) | 6.21 | 15.98 |
| Price to Book (MRQ) | 3.64 | 7.33 |
| Market Capitalization | ||
| Market Capitalization | $7.72B | $45.62B |
| Enterprise Value | $8.54B | $39.63B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 6.87 | 13.88 |
| Enterprise to EBITDA | 21.05 | 48.88 |
| Risk & Other Metrics | ||
| Beta | 0.54 | 0.96 |
| Book Value per Share (MRQ) | $24.49 | $38.11 |
Financial Statements Comparison: HealthEquity vs Veeva Systems
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | HQY | VEEV |
|---|---|---|
| Revenue/Sales | $330.84M | $759.04M |
| Cost of Goods Sold | $106.53M | $173.82M |
| Gross Profit | $224.31M | $585.22M |
| Research & Development | $61.44M | $184.03M |
| Operating Income (EBIT) | $84.35M | $233.73M |
| EBITDA | $125.83M | $243.55M |
| Pre-Tax Income | $70.95M | $298.82M |
| Income Tax | $17.04M | $70.63M |
| Net Income (Profit) | $53.92M | $228.19M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | HQY | VEEV |
|---|---|---|
| Cash & Equivalents | $287.89M | $1.96B |
| Total Current Assets | $472.80M | $6.71B |
| Total Current Liabilities | $116.34M | $1.46B |
| Long-Term Debt | $1.10B | $66.57M |
| Total Shareholders Equity | $2.12B | $6.21B |
| Retained Earnings | $218.35M | $3.68B |
| Property, Plant & Equipment | $41.45M | $122.23M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | HQY | VEEV |
|---|---|---|
| Operating Cash Flow | $64.74M | $810.54M |
| Capital Expenditures | $-86,000 | N/A |
| Free Cash Flow | $48.60M | $877.16M |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | $-59.07M | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | HQY | VEEV |
|---|---|---|
| Shares Short | 4.80M | 4.62M |
| Short Ratio | 5.51 | 3.58 |
| Short % of Float | 0.06% | 0.03% |
| Average Daily Volume (10 Day) | 981,810 | 1,023,150 |
| Average Daily Volume (90 Day) | 898,080 | 1,195,860 |
| Shares Outstanding | 86.54M | 162.58M |
| Float Shares | 84.86M | 149.92M |
| % Held by Insiders | 0.02% | 0.09% |
| % Held by Institutions | 1.07% | 0.88% |
Dividend Analysis & Yield Comparison: HealthEquity vs Veeva Systems
| Metric | HQY | VEEV |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |